James Lang

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when OptimizeRx Corp publishes a filing, an earnings call transcript or a press release.

Get OPRX alerts

About James Lang

James Lang is recorded as Board Member at OptimizeRx Corp (OPRX) since January 1, 2017 and Board Member at Biovie Inc. (BIVI) since January 1, 2016. The newest filing on record that lists James Lang as Board Member at OptimizeRx Corp (OPRX) is dated April 30, 2026. The newest filing on record that lists James Lang as Board Member at Biovie Inc. (BIVI) is dated September 28, 2026. OptimizeRx Corp reported in an 8-K filed June 12, 2026 that James Lang was appointed director, effective June 9, 2026. OptimizeRx Corp reported in an 8-K filed June 7, 2024 that James Lang was appointed director, effective June 5, 2024. Biovie Inc. is classified in the Biotechnology industry within the Healthcare sector. OptimizeRx Corp is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at Biovie Inc. includes Cuong V. Do (CEO), Jim Lang (Chairman), Jonathan Adams (COO) and 7 others.

“The following nominees were each elected to serve as director for a term that expires at the next annual meeting of shareholders and until his or her successor has been elected and qualified or until his or her earlier death, resignation or removal based upon the following votes:”

OptimizeRx Corp Form 8-K, filed June 12, 2026 · Read the filing

“The following nominees were each elected to serve as director for a term that expires at the next annual meeting of stockholders and until his or her successor has been elected and qualified or until his or her earlier death, resignation or removal based upon the following votes:”

OptimizeRx Corp Form 8-K, filed June 7, 2024 · Read the filing

Affiliation history

OptimizeRx Corp (OPRX)
Board Member

Proxy statement

Current
2017-01-01–present

Last confirmed April 30, 2026
Biovie Inc. (BIVI)
Board Member

Proxy statement

Current
2016-01-01–present

Last confirmed September 28, 2026